Genomic Valley Biotech: Board Meeting Intimation for Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the audited financial results (standalone) of the Company for the quarter and year ended March 31 2025.